ConductScience.org, home

Paper10073741

Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.

Schäfers RF and 5 others. Br J Clin Pharmacol, 1999. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers. Papers, record 10073741. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10073741

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1999
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.05
iCite
Revised in PubMed
2019-05-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schäfers RFR F
2Karl II
3Mennicke KK
4Daul AEA E
5Philipp TT
6Brodde OEO E

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
Anti-Allergic AgentsMajor topic
HemodynamicsMajor topic
KetotifenMajor topic
XamoterolMajor topic
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Drug Interactions
Electrocardiography
Humans
Isoproterenol
Male
Placebos
Reproducibility of Results
Tachycardia

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13720553[Tolerance development during a 1-week course of dobutamine treatment].Dtsch Med Wochenschr1986https://conductscience.org/library/papers/3720553PubMed
22872245Adrenergic therapy of bronchial asthma.J Allergy Clin Immunol1986https://conductscience.org/library/papers/2872245PubMed
32830792Differentiation of beta 1- and beta 2-adrenoceptor-mediated effects in humans.Am J Physiol1988https://conductscience.org/library/papers/2830792PubMed
42839668Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.J Pharmacol Exp Ther1988https://conductscience.org/library/papers/2839668PubMed
52455840The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.J Cardiovasc Pharmacol1988https://conductscience.org/library/papers/2455840PubMed
63207552Correction of systolic time intervals for heart rate: a comparison of individual with population derived regression equations.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3207552PubMed
72574108Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.Eur Heart J1989https://conductscience.org/library/papers/2574108PubMed
81968366Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.Circulation1990https://conductscience.org/library/papers/1968366PubMed
91971589Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol.Eur Heart J1990https://conductscience.org/library/papers/1971589PubMed
101677200Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure.Pharmacol Rev1991https://conductscience.org/library/papers/1677200PubMed
111279289Terbutaline-induced desensitization of beta 2-adrenoceptor in vivo function in humans: attenuation by ketotifen.J Cardiovasc Pharmacol1992https://conductscience.org/library/papers/1279289PubMed
128144793Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.J Am Coll Cardiol1994https://conductscience.org/library/papers/8144793PubMed
139050018Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine.Naunyn Schmiedebergs Arch Pharmacol1997https://conductscience.org/library/papers/9050018PubMed
149876334Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.Cardiovasc Res1998https://conductscience.org/library/papers/9876334PubMed
15872305A critical review of the systolic time intervals.Circulation1977https://conductscience.org/library/papers/872305PubMed
167405947Tolerance to dobutamine after a 72 hour continuous infusion.Am J Med1980https://conductscience.org/library/papers/7405947PubMed
176125416Mechanisms of hormone receptor-effector coupling: the beta-adrenergic receptor and adenylate cyclase.Fed Proc1982https://conductscience.org/library/papers/6125416PubMed
186128041The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.Br J Pharmacol1982https://conductscience.org/library/papers/6128041PubMed
196854129Heart rate responsiveness after sustained chronotropic stimulation with a beta 1-adrenergic receptor agonist.J Lab Clin Med1983https://conductscience.org/library/papers/6854129PubMed
206146637Measurement of xamoterol in plasma and urine by high-performance liquid chromatography.J Chromatogr1984https://conductscience.org/library/papers/6146637PubMed

See all 24 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
17420778Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.Br J Pharmacol2007https://conductscience.org/library/papers/17420778

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADRB1153PubTator's text mininghttps://conductscience.org/library/genes/153NCBI Gene
ADRB2154PubTator's text mininghttps://conductscience.org/library/genes/154NCBI Gene
MS4A1931PubTator's text mininghttps://conductscience.org/library/genes/931NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10073741

GET https://conductscience.org/api/papers/v1/10073741/references?page=2